A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
about
Challenging Treatment-Resistant Major Depressive Disorder: A Roadmap for Improved TherapeuticsOptimizing the Use of Aripiprazole Augmentation in the Treatment of Major Depressive Disorder: From Clinical Trials to Clinical PracticeLSD-induced entropic brain activity predicts subsequent personality change.Long-term treatment of depression with antidepressants: a systematic narrative review.The Impact of Residual Symptoms in Major DepressionPharmacologic approaches to treatment resistant depression: a re-examination for the modern era.Alpha2-adrenoceptor blockade accelerates the neurogenic, neurotrophic, and behavioral effects of chronic antidepressant treatment.Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders.An Evidence-Based Approach to Augmentation and Combination Strategies for: Treatment-Resistant Depression.The therapeutic role of 5-HT1A and 5-HT2A receptors in depression.Efficacy and safety of olanzapine/fluoxetine combination vs fluoxetine monotherapy following successful combination therapy of treatment-resistant major depressive disorder.Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 2000 British Association for Psychopharmacology guidelines.Development of frontotemporal dementia in a case of bipolar affective disorder: is there a link?Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol.Advances in the Management of Treatment-Resistant DepressionMedication options in the treatment of treatment-resistant depression.COMBINED MIRTAZAPINE AND SSRI TREATMENT OF PTSD: A PLACEBO-CONTROLLED TRIAL.Efficacy and safety of add on low-dose mirtazapine in depressionTherapeutic alternatives for difficult-to-treat depression: a narrative review of the state of the evidence.Therapy of treatment resistant depression: focus on the management of TRD with atypical antipsychotics.Pharmacologic approaches to treatment resistant depression: Evidences and personal experience.Mirtazapine: a review of its clinical efficacy and tolerability.Combined antidepressants: clinical experience.Augmentation and combination strategies for depression.Combination pharmacotherapy in unipolar depression.Quality of life of 'normal' controls: association with lifetime history of mental illness.Combining Antidepressants in Acute Treatment of Depression: A Meta-Analysis of 38 Studies Including 4511 PatientsCombined treatments for major depression.Augmentation treatment in major depressive disorder: focus on aripiprazoleThe drugs don't work? antidepressants and the current and future pharmacological management of depression.Current trends in the assessment and somatic treatment of resistant/refractory major depression: an overview.Trazodone Addition to Paroxetine and Mirtazapine in a Patient with Treatment-Resistant Depression: The Pros and Cons of Combining Three Antidepressants.Non-tricyclic and Non-selective Serotonin Reuptake Inhibitor Antidepressants and Recurrent Falls in Frail Older Women.A review of therapeutic uses of mirtazapine in psychiatric and medical conditions.Two cases of mild serotonin toxicity via 5-hydroxytryptamine 1A receptor stimulation.Evidence-based, pharmacological treatment guideline for depression in Korea, revised edition.Therapeutic armamentarium for treating depression.Therapeutic options in treatment-resistant depression.Targeting treatment-resistant depression.How should primary care doctors select which antidepressants to administer?
P2860
Q26782997-3F9EAFE2-DAA5-43F4-8F00-682A6BD3B82BQ26797416-DCA196DC-D9E9-4294-99AD-8FF757D58DBAQ30387757-4D0F3BDA-B5E4-4006-B4DD-55118446789AQ33303427-53C45ACE-1783-48BF-9663-301BEDBA2BA3Q33664080-B0A22849-B616-4D9A-BEBD-AA9FB5946A56Q33716723-FA2F7693-40FB-41C3-9D8B-400B3268754EQ33893155-26BE3D23-C0BE-437A-853F-9CEA8C570BFDQ34177643-C93D7310-D0BB-48D6-99F3-62CC38C54B7AQ34220649-D6F3BAA1-70A5-46FF-B68B-E27CC45D376BQ34340909-08B01E27-EF32-4B7F-A571-CACA8B501D0FQ34393030-E796B657-8EFF-425D-90A8-EE5F3D350879Q34590507-E04F94B4-97D5-47FE-B907-C6B307E78274Q34707367-89B598F2-B3EA-4363-BBEE-BFE217A1F3D0Q35061175-D81ADF98-406B-47A8-A565-5D5B24236475Q35580600-874C6C4F-F473-4C08-877A-E7DBF4C8039FQ35707515-B28888DE-43FC-46FC-B6C5-4C7885EA7D55Q35889371-73EC4BE1-64DA-4AFB-8A14-CE35D548464CQ35890382-BA316DC9-4660-4D0C-B39D-504916BC8E92Q35936247-5545091B-986E-41E0-934C-9CEAED000406Q35936252-F315C624-C581-404F-ABD6-4F5B481E76E5Q36091234-53B0E0DB-27A1-4AD0-9356-CF92D162077BQ36150725-1290D7C3-641C-46D7-BCF7-52CD421020EEQ36322238-E0E17BC3-1E02-43A3-9D2B-B91EED0F3AB2Q36462566-90F4BD42-5210-40B0-BA4E-59485D25C485Q36532163-63F2E75A-9F68-4646-9065-55A2B70E060EQ36535169-A6B6A7CC-6341-4A60-A785-7565B4170FADQ36588313-8D1A4269-14C8-4621-9522-95F97C1B1817Q36916862-31C98819-3EA7-4524-9DDA-FEFCA7906181Q37062552-4DB0D944-0EDE-4975-A271-5CC7C564D41FQ37079049-CD318F52-4E2F-47B9-85E1-2A404CBC89B4Q37091883-ED478D9F-8AF2-45B5-84B9-27FEE9BFE09AQ37363644-76333B48-BDC4-41F5-B4B9-A407B1CCBD28Q37470696-3FB70FD1-C46F-402F-9E1A-E867FF300FA0Q37533880-6FCDE002-94AF-4F5E-A696-C88817532201Q37597598-7C446AF8-F248-455E-9D68-1D4BE9FF8301Q37710333-0009D813-B76D-43E0-8A07-27C53573942AQ37777008-04647744-C6EA-433F-9BAD-7CB4AB967A1AQ37881968-0A59FB4B-9487-4F65-8942-D343BD06702BQ37957770-AE249C22-433C-4B02-AFDA-77068948757AQ38014710-BCA22CCA-B852-4FB7-9778-070DB8B55C56
P2860
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@en
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@nl
type
label
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@en
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@nl
prefLabel
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@en
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@nl
P2093
P1476
A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine.
@en
P2093
Lawrence H Price
Linda L Carpenter
Sarah Yasmin
P304
P356
10.1016/S0006-3223(01)01262-8
P407
P577
2002-01-01T00:00:00Z